August 28, 2020
NIAID researchers and their colleagues have developed the first detailed “atlas” of the insect’s immune cells, and discovered a new cell type that may play a role in helping mosquitoes resist infection by malaria-causing parasites. The information contained in this immune atlas may lead to new ways to prevent mosquitoes from transmitting malaria parasites to people.
June 12, 2020
In a new study published this week in The Lancet, NIAID scientists describe the results of a small Phase 1 trial of a vaccine designed to provide broad protection against mosquito-borne diseases. The trial indicated that the vaccine is safe and induces a strong immune response in healthy volunteers.
October 25, 2019
In recent months, an uptick in cases of eastern equine encephalitis virus (EEEV) infections in Connecticut, Massachusetts, Michigan, and elsewhere in the United States has raised alarm. At NIAID, researchers are working to develop both vaccines and therapeutics to fight this rare but deadly virus.
August 28, 2019
NIAID-funded researchers can use viral genomes to trace the spread of the Zika virus, and uncover outbreaks that were previously undetected.
July 30, 2019
Researchers investigate the puzzling phenomenon of why mosquitoes prefer to bite some people over others in an effort to find new ways to prevent mosquitoes from finding and biting people, and, ultimately, reduce the transmission of mosquito-borne diseases.
June 11, 2019
A weapon made from spider toxin destroys blood-sucking enemies from the inside and helps save people from disease and death. It sounds like the plot of a superhero movie, but it’s actually a new way to combat malaria. NIAID-funded researchers who developed a genetically modified mosquito-killing fungus and tested it in the West African nation of Burkina Faso have shown that it even works against mosquitoes that have become resistant to chemical insecticides.
April 12, 2019
Malaria is caused by a tiny parasite that infects human livers and red blood cells, and which is transmitted from person to person by a female mosquito. NIAID-funded researchers investigated how the parasite takes nutrients to complete completes critical life stages inside a mosquito without harming the mosquito's ability to lay eggs.
March 01, 2019
Tickborne diseases are a growing problem in the United States. In response to recommendations from the Tick-borne Disease Working Group, the NIH is developing a strategic plan to advance tickborne disease research and development, and is seeking comments and suggestions from stakeholders throughout the scientific research, advocacy, and clinical practice communities, and the general public.
November 16, 2018
Curious about where challenge trials take place on the NIH campus? Dr. Matthew Memoli led a livestreamed “virtual tour” of the Special Clinical Studies Unit, where Ebola patients were cared for and where participants in challenge trials of influenza, RSV, and other pathogens stay while they are infectious.
October 12, 2018
An advanced electron microscopy technique has given scientists a clearer picture of a molecule used by insects to smell their way around.
August 27, 2018
NIH Director Francis S. Collins, M.D., Ph.D., keeps the public posted on fascinating NIH-supported research in biweekly posts on the NIH Director's Blog. The blog features the work of scientists from many of NIH's institutes and centers, as well as NIH grantees and collaborators, and NIAID is no exception.
August 20, 2018
August 20 is World Mosquito Day. NIAID is part of the fight against these death-dealing insects.
April 20, 2018
In 2016, an estimated 216 million people developed malaria. In a new video from NIAID, Dr. Lee Hall, chief of the Parasitology and International Programs Branch in NIAID’s Division of Microbiology and Infectious Diseases, discusses the urgent need for malaria research, and how NIAID is supporting and conducting investigation into new diagnostics, drugs, vaccines and more.